Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
286 hedge funds and large institutions have $2.55B invested in Amicus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 115 increasing their positions, 88 reducing their positions, and 40 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 88
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
0% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 40
0.43% less ownership
Funds ownership: 102.2% → 101.76% (-0.43%)
1% less funds holding
Funds holding: 290 → 286 (-4)
11% less capital invested
Capital invested by funds: $2.88B → $2.55B (-$324M)
36% less call options, than puts
Call options by funds: $3.21M | Put options by funds: $5.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.6M |
| 2 |
Millennium Management
New York
|
+$26.9M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$22.9M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$14.5M |
| 5 |
Two Sigma Investments
New York
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$28.6M |
| 2 |
PA
Perceptive Advisors
New York
|
-$25.7M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$24.8M |
| 4 |
JP Morgan Chase
New York
|
-$21.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.79M |
FOLD Hedge Fund Activity: Q1 2025 in Review
286 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q1 2025, worth a combined $2.55B — down 11% from $2.88B a quarter earlier.
Fund positioning in FOLD was balanced in Q1 2025: 40 funds opened new positions, 40 closed out, 115 added to existing stakes and 88 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $27.6M. The largest seller was Fiera Capital (Canada), exiting entirely with an estimated $28.6M sold.
- 286 institutional investors held Amicus Therapeutics (FOLD) as of Q1 2025, down from 290 in Q4 2024.
- Funds reported $2.55B of Amicus Therapeutics stock for Q1 2025, down 11% quarter-over-quarter.
- 40 funds opened new Amicus Therapeutics positions in Q1 2025 and 40 closed out, a net change of 0 holders.
- The largest Amicus Therapeutics buyer in Q1 2025 was Point72 Asset Management, an estimated $27.6M added.
- The largest Amicus Therapeutics seller in Q1 2025 was Fiera Capital (Canada), an estimated $28.6M sold.
Based on aggregated 13F filings for Q1 2025.